Cc1ccc(O)c(-c2csc(NCN3CCN(CNc4nc(-c5cc(C)ccc5O)cs4)CC3)n2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?